WASHINGTON (AP) — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday. Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop drugs that can target the protein have [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows | 2 | 7 | 14-07-2026 |
| 2 | New experimental Alzheimer’s drug shows potential after study shows slower cognitive decline | 2 | 6 | 14-07-2026 |
| 3 | Scientists may have finally found how Alzheimer's spreads through the brain | 0 | 7.51 | 30-06-2026 |
| 4 | A little-known protein may be fueling Alzheimer’s — and scientists found a way to block it | 0 | 8.12 | 17-08-2026 |
| 5 | Scientists May Have Found What Really Triggers Alzheimer’s Disease | 2 | 7 | 19-06-2026 |
| 6 | Tau levels fall, cognitive decline slows with diranersen | 0 | 9.46 | 04-08-2026 |
| 7 | Scientists discover a protein that protects the brain from Alzheimer’s damage | 0 | 6.05 | 20-07-2026 |
| 8 | Two new compounds could reveal hidden drivers of Alzheimer’s disease | 0 | 5.8 | 03-08-2026 |
| 9 | В Британии представили результаты генной терапии от болезни Альцгеймера | 5 | 7 | 16-07-2026 |
| 10 | Найден способ отсрочить развитие болезни Альцгеймера на три года | 7 | 8 | 16-07-2026 |